Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Blazeck

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Current Opinion in Biomedical Engineering|October 21, 2024
Exploiting protein domain modularity to enable synthetic control of engineered cellsYusef Haikal, John Blazeck
Biotechnology Journal|February 13, 2010
Systems metabolic engineering: genome-scale models and beyondJohn Blazeck, Hal Alper
Journal of Biological Engineering|December 27, 2022
High throughput mutagenesis and screening for yeast engineeringKendreze Holland, John Blazeck
Biotechnology Journal|August 5, 2021
Advances in promoter engineering: Novel applications and predefined transcriptional controlAndrew P Cazier, John Blazeck
Metabolic Engineering|November 3, 2024
Applying metabolic control strategies to engineered T cell cancer therapiesAndrea C Fox, John Blazeck
Trends in Biotechnology|October 10, 2021
Protein engineering: a driving force toward synthetic immunologyJohn R Cox, John Blazeck
Biotechnology Journal|August 15, 2012
Promoter engineering: recent advances in controlling transcription at the most fundamental levelJohn Blazeck, Hal S Alper
Journal of Biotechnology|February 14, 2012
Evolution of an alkane-inducible biosensor for increased responsiveness to short-chain alkanesBen Reed, John Blazeck, Hal Alper
Journal for Immunotherapy of Cancer|October 20, 2021
Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forwardMaria Rain Jennings, David Munn, John Blazeck
Applied and Environmental Microbiology|September 20, 2011
Tuning gene expression in Yarrowia lipolytica by a hybrid promoter approachJohn Blazeck, Leqian Liu, Heidi Redden, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Current Opinion in Biomedical Engineering|October 21, 2024
Exploiting protein domain modularity to enable synthetic control of engineered cellsYusef Haikal, John Blazeck
Biotechnology Journal|February 13, 2010
Systems metabolic engineering: genome-scale models and beyondJohn Blazeck, Hal Alper
Journal of Biological Engineering|December 27, 2022
High throughput mutagenesis and screening for yeast engineeringKendreze Holland, John Blazeck
Biotechnology Journal|August 5, 2021
Advances in promoter engineering: Novel applications and predefined transcriptional controlAndrew P Cazier, John Blazeck
Metabolic Engineering|November 3, 2024
Applying metabolic control strategies to engineered T cell cancer therapiesAndrea C Fox, John Blazeck
Trends in Biotechnology|October 10, 2021
Protein engineering: a driving force toward synthetic immunologyJohn R Cox, John Blazeck
Biotechnology Journal|August 15, 2012
Promoter engineering: recent advances in controlling transcription at the most fundamental levelJohn Blazeck, Hal S Alper
Journal of Biotechnology|February 14, 2012
Evolution of an alkane-inducible biosensor for increased responsiveness to short-chain alkanesBen Reed, John Blazeck, Hal Alper
Journal for Immunotherapy of Cancer|October 20, 2021
Immunosuppressive metabolites in tumoral immune evasion: redundancies, clinical efforts, and pathways forwardMaria Rain Jennings, David Munn, John Blazeck
Applied and Environmental Microbiology|September 20, 2011
Tuning gene expression in Yarrowia lipolytica by a hybrid promoter approachJohn Blazeck, Leqian Liu, Heidi Redden, et al.
Pageof 4